Acute variceal bleeding: General management

World Journal of Gastroenterology

Volumn 7, Issue 4, 2001, Pages 466-475

  Patch, D ^a   Dagher, L ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; ALBUMIN; ANTIBIOTIC AGENT; ANTIFIBRINOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUCRILATE; CLOMETHIAZOLE; DESMOPRESSIN; DOPAMINE; ENBUCRILATE; FIBRIN GLUE; LACTULOSE; NITRATE; OCTREOTIDE; PLACEBO; POLIDOCANOL; QUINOLONE DERIVATIVE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SOMATOSTATIN; TERLIPRESSIN; VASOPRESSIN;

ALCOHOL WITHDRAWAL; AORTA BALLOON; ASCITES; BLOOD TRANSFUSION; CLINICAL TRIAL; ENCEPHALOMYOPATHY; ERYTHROCYTE TRANSFUSION; ESOPHAGUS HEMORRHAGE; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HEART TAMPONADE; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; KIDNEY FAILURE; KIDNEY FUNCTION; LIGATION; LIVER DYSFUNCTION; NUTRITIONAL SUPPORT; REVIEW; SCLEROTHERAPY; SEPSIS; STENT; STOMACH VARICES; TREATMENT OUTCOME;

EID: 0034882260     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i4.466     Document Type: Review

References (117)

1. The treatment of portal hypertension: A metanalytic review
2. Cirrhotics with variceal hemorrhage: The importance of the time interval between admission and the start of analysis for survival and rebleeding rates
3. Portal hypertension and variceal bleeding: An AASLD single topic symposium
4. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage
5. A predictive model for failure to control bleeding during acute variceal haemorrhage
6. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure
7. Prognostic value of early measurements of portal pressure in acute variceal bleeding
8. Endoscopy in patients with portal hypertension and upper gastrointestinal bleeding
9. Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage
10. Prognostic significance of the white nipple sign in variceal bleeding
11. Balloon tamponade in variceal bleeding: Use and misuse
12. Prediction of outcome following acute variceal haemorrhage
13. Prognostic factors in upper gastrointestinal bleeding
14. Frequency of infection in cirrhotic patients presenting with gastrointestinal haemorrhage
15. Predictors of mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis
16. Long-term follow up of gastric variceal sclerotherapy: An eleven year experience
17. A predictive model for very early rebleeding from varices
18. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage
19. Abnormalities in organ blood flow and its distribution during expiratory pressure ventilation
20. What is the factual basis, in theory and practice, for the use of fresh frozen plasma
21. Abnormal haemoglobin-oxygen affinity and surgical haemotherapy
22. Subcutaneous desmopressin shortened the prolonged bleeding time in patients with cirrhosis
23. Desmopressin and bleeding time in patients with cirrhosis
24. Terlipressin plus desmopressin versus terlipressin alone in acute variceal haemorrhage in cirrhotics: Interim analysis of double blind multicentre placebo controlled trial
25. Impact of aprotonin on blood transfusion requirements in liver transplantation
26. Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection
27. Antibiotic prophylaxis (AbP) for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding (GB): A meta-analysis
28. Bacterial infection in the pathogenesis of variceal bleeding
29. Response to dopamine hydrochloride in the hepatorenal syndrome
30. Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome
31. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality
32. Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis
33. Hepatorenal syndrome: Long-term treatment with terlipressin as a bridge to liver transplantation
34. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome
35. Malnutrition in cirrhotic patients: Antropometric measurements as method of assessing nutritional status
36. Effect of intravenously administered posterior pituitary extract on haemorrhage from bleeding oesophageal varices
37. Continuous intravenous vasopressin in active upper gastrointestinal bleeding: A placebo controlled trial
38. Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: A prospective, controlled clinical trial
39. Selective intraarterial vasopressin infusion for upper gastrointestinal tract hemorrhage: A controlled trial
40. Terlipressin in bleeding esophageal varices: A placebo-controlled, double-blind study
41. Placebo controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding
42. Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial
43. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients
44. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices
45. Randomised, double-blind, placebo-controlled trial of somatostatin for variceal bleeding
46. Somatostatin vs placebo in bleeding esophageal-varices-randomized trial and meta analysis
47. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage
48. For the veterans cooperative variceal sclerotherapy group. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis
49. Controlled trial of injection sclerotherapy for active variceal bleeding
50. Randomised controlled trial comparing terlipressin vs endoscopic injection sclerotherapy in the treatment of acute variceal bleeding and prevention of early rebleeding
51. A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding esophageal-varices
52. A prospective randomised trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding
53. Somatostatin (SMS) and urgent sclerotherapy (US) in active oesophageal variceal bleeding
54. Octreotide infusion or emergency sclerotherapy for variceal hemorrhage
55. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage
56. Octreotide versus emergency sclerotherapy in acute variceal haemorrhage in liver cirrhosis
57. Octreotide vs sclerotherapy in the treatment of acute variceal bleeding
58. Octreotide vs sclerotherapy in the control of acute variceal bleeding in schistosomal portal hypertension: A randomized trial
59. Sclerotherapy with or without octreotide for acute variceal bleeding
60. Propranolol in the prevention of recurrent upper gastrointestinal-bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy - A randomized controlled trial
61. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial
62. Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: Our experience
63. Sclerotherapy alone vs sclerotherapy plus terlipressin vs sclerotherapy plus octreotide in the treatment of acute variceal haemorrhage
64. Esophageal varices bleeding: Comparison between treatment with sclerotherapy alone vs sclerotherapy plus octreotide
65. Propranolol in prevention of rebleeding from esophageal-varices during the course of endoscopic sclerotherapy
66. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices
67. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices
68. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices
69. A prospective randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices
70. Comparison of variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial
71. Management of acute variceal bleed: Randomised trial of variceal ligation and sclerotherapy
72. Prospective randomised comparative randomised comparative study of injection sclerotherapy and band ligation for bleeding esophageal varices
73. Prospective randomised trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence
74. Endoscopic variceal ligation versus endoscopic sclerotherapy for the management of bleeding varices: A prospective randomised trial
75. Endoscopic sclerotherapy versus endoscopic variceal ligation for the management of bleeding varices: A final report of prospective randomised study in schistosomal hepatic fibrosis
76. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding esophageal varices
77. Initial results of randomised prospective study of emergency banding versus sclerotherapy for bleeding gastric or esophageal varices
78. Endoscopic sclerotherotherapy versus esophageal transection in child class C patients with variceal hemorrhage. Comparison with results of portocaval shunt. Preliminary report
79. Oesophageal transection versus injection sclerotherapy in the management of bleeding oesophagela varices in patients at high risk
80. Randomised trial of portocaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding
81. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices
82. Prospective randomised trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotics patients with bleeding varices
83. N-butyl-2-cyanoacrylate: A supplement to endoscopic sclerotherapy
84. Emergency endoscopic strategies for improved outcomes
85. N-butyl-cyanoacrilate (Histoacryl) plus sclerotherapy alone in the treatment of bleeding esophageal varices: A randomised prospective study
86. The vaule of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding oesophagogastric varices
87. Banding is superior to cyanoacrylate for the treatment of esophageal variceal bleeding. A prospective randomised study
88. A prospective randomised trial of cyanoacrylate (CYA) versus endoscopic variceal ligation (EVL) for acute esophagastric variceal hemorrhage
89. Endoscopic sclerotherapy with fibrin glueas compared with polidocanol to prevent early esophageal variceal rebleeding
90. Prognosis of patients with cirrhosis and chronic liver disease admitted to a medical intensive care unit
91. Portal hypertension II
92. Updating consensus in portal hypertension: Report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension
93. Prospective study on the application of the Beveno II consensus conference criteria in patients with cirrhosis and gastrointestinal bleeding
94. Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding
95. A comparison of sclerotherapy with staple transection of the oesophagus for the emergency control of bleeding from oesophageal varices
96. Efficacy of balloon tamponade in treatment of bleeding gastric and oesophageal varices. Results in 151 consecutive episodes
97. "Salvage" transjugular intrahepatic portosystemic shunts: Gastric fundal compared with esophageal variceal bleeding
98. Successful therapy of bleeding duodenal vatces by TIPS after failure of sclerotherapy
99. Massive bleeding from ileal conduit peristomal varices: Successful treatment with the transjugular intrahepatic portosystemic shunt
100. Acute hemperitoneum after large volume paracentesis
101. Transjugular intrahepatic portosystemic shunt in the treatment of intermittently bleeding stomal varices
102. Transjugular portosystemic shunt for treatment of bleeding stomal varices
103. Rectal varices bleeding treated by transjugular intrahepatic portosystemic shunt. Potentials and pitfalls
104. Transjugular intrahepatic portosystemic shunt in an infant
105. Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report
106. Emergency transjugular intrahepatic portosystemic shunt prior to liver transplantation
107. Transjugular portosystemic shunts in pediatric patients awaiting liver transplantation
108. Transjugular intrahepatic portosystemic shunt creation in children: Initial clinical experience
109. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage
110. Transjugular intrahepatic portosystemic shunt: Decreased survival for patients with high APACHE II scores
111. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following transjugular intrahepatic portosystemic stent shunt for variceal haemorrhage
112. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding
113. Training and validation of an artificial neural network to predict early mortality in patients undergoing the transjugular intrahepatic portosystemic stent shunt (TIPSS) for variceal haemorrhage: Analysis of data on 398 patients from two centres
114. Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension. Comparison of emergency and elective intervention
115. Factors related to early mortality after transjugular intrahepatic portosystemic shunts (TIPS) for uncontrolled variceal haemorrhage
116. Emergency TIPS as salvage treatment for uncontrolled variceal bleeding
117. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy